These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2829862)

  • 1. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine binding sites in pig ventricular sarcolemma and interaction with calcium channels.
    Ronca-Testoni S; Poddighe R; Zucchi R
    Int J Tissue React; 1988; 10(2):89-93. PubMed ID: 2846460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
    Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors.
    Haase H; Vetter R; Will H; Will-Shahab L
    Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma.
    Miwa N; Kanaide H; Nishimura J; Nakamura M
    Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
    Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
    Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
    Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats.
    Garthoff B; Bellemann P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S36-9. PubMed ID: 2455136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
    Schilling WP; Zaher MC; Rampe D
    Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
    Sarmiento JG; Shrikhande AV; Janis RA; Triggle DJ
    J Pharmacol Exp Ther; 1987 Apr; 241(1):140-6. PubMed ID: 2437286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethaverine, a derivative of papaverine, inhibits cardiac L-type calcium channels.
    Wang Y; Rosenberg RL
    Mol Pharmacol; 1991 Nov; 40(5):750-5. PubMed ID: 1658607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of verapamil binding sites in cardiac membrane vesicles.
    Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity binding sites for [3H] verapamil in cardiac membranes.
    Hulthén UL; Landmann R; Bürgisser E; Bühler FR
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S291-3. PubMed ID: 6184555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
    Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
    J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.